CCL2 and hand-foot-genital syndrome: The increase seen in IL-6, CXCL-10 and CCL-2 gene expressions induced by HFg was ameliorated when astrocytes were treated with function-blocking ICAM-1 antibody or PrPC function-blocking peptide (Figure 2A).